2024-03-27 | Sale | Nuvalent, Inc. NUVL | director | 880,000 1.3042% | $72.77 | $64.04M | -8.93% | |
2023-08-08 | Sale | Dynavax Technologies Corporation DVAX | director | 1.5M 1.1284% | $14.39 | $21.59M | -10.24% | |
2023-06-14 | Sale | Dynavax Technologies Corporation DVAX | director | 500,000 0.3927% | $12.68 | $6.34M | +6.26% | |
2023-05-18 | Sale | Dynavax Technologies Corporation DVAX | director | 1M 0.7525% | $10.55 | $10.55M | +22.38% | |
2022-12-06 | Sale | Dynavax Technologies Corporation DVAX | director | 1.5M 1.4875% | $11.60 | $17.4M | +1.85% | |
2022-11-03 | Nuvalent, Inc. NUVL | director | 298,506 0.6374% | $33.50 | $10M | +32.21% | ||
2022-08-15 | Sale | Dynavax Technologies Corporation DVAX | 3M 2.219% | $14.68 | $44.04M | -27.66% | ||
2022-05-31 | Mersana Therapeutics, Inc. MRSN | 14,760 0.0148% | $3.20 | $47,182 | +90.72% | |||
2022-05-24 | Mersana Therapeutics, Inc. MRSN | 75,000 0.0765% | $3.19 | $238,943 | +88.96% | |||
2022-05-23 | Mersana Therapeutics, Inc. MRSN | director | 15,599 0.0162% | $3.35 | $52,247 | +83.04% | ||
2022-05-20 | Mersana Therapeutics, Inc. MRSN | director | 100,000 0.1034% | $3.46 | $345,570 | +75.07% | ||
2022-05-19 | Mersana Therapeutics, Inc. MRSN | 115,599 0.1213% | $3.47 | $400,867 | +76.52% | |||
2022-05-18 | Mersana Therapeutics, Inc. MRSN | director | 211,268 0.2245% | $3.35 | $707,262 | +84.19% | ||
2022-05-17 | Mersana Therapeutics, Inc. MRSN | director | 3,440 0.0034% | $3.18 | $10,952 | +79.82% | ||
2022-05-16 | Mersana Therapeutics, Inc. MRSN | 138,732 0.1441% | $3.10 | $430,398 | +93.91% | |||
2022-04-13 | Mersana Therapeutics, Inc. MRSN | 1.23M 1.1527% | $4.05 | $5M | +28.04% | |||
2022-04-12 | Mersana Therapeutics, Inc. MRSN | 1.2M 1.3086% | $4.18 | $5M | +45.36% | |||
2022-02-07 | Mersana Therapeutics, Inc. MRSN | director | 2.27M 2.7929% | $4.42 | $10.05M | +25.11% | ||
2021-12-30 | Mersana Therapeutics, Inc. MRSN | director | 1.63M 2.2192% | $6.15 | $10.02M | -17.11% | ||
2021-12-29 | Mersana Therapeutics, Inc. MRSN | director | 1.75M 2.4751% | $5.75 | $10.06M | -7.9% |